Division Director of Hematology/Oncology, Associate Director - Clinical Affairs at the cancer institute @ummc_cancer @ummcMedicine 🫁 Oncology, QI/Safety Expert
Madison,MS
Joined October 2017
- Tweets9.9K
- Following2.8K
- Followers5.8K
- Likes47.8K
Devika Das, MD, MSHQS, FASCO retweeted
📣📣📣
Keep your calendars ready for Oct 29, 7:00 PM CST for the first webinar of 2026 by the volunteer led American Society of Clinical Oncology (ASCO) Health Policy Webinar.
@ASCO @healthpolicycop
We will hear from stellar speakers -
@montypal @PGrivasMDPhD and Stephanie Ohlman and share perspectives from previous Communities of Practice members and volunteers and members. 🥳🥳
If we are not on the table, we are on the menu! #Advocacy and #Policy are not a choice, it’s a need of our times.
Thank you @yuan_ruiling @WadeSwenson for putting this amazing agenda together.. 👏👏
@oncology101_org @RobinZo23059606 @jrgralow @cityofhope @COH_RadOnc @fredhutch @ASCOPost @JCOOP_ASCO @IMG_Oncologists @oncologyCOA @ASCOTECAG @ASCOPres
This is why I love these meetings! Great to run into an amazing mentor and leader at @ASCO
Wonderful day 1 of chiefs and chairs leadership development day!
Looking forward to day 2
@UMMC_Cancer @UMMCnews
Devika Das, MD, MSHQS, FASCO retweeted
Great time at 2026 Nashville Hematology Summit organized by @binaytara. Had the opportunity to debate FOR bispecifics in r/r DLBCL: can’t get A (access!) to C (cancer control/cost effective care/CAR-T) without B (easily accessible, ❓durable, bridging BITEs!!) @UTMDAnderson
Devika Das, MD, MSHQS, FASCO retweeted
@ONealCancerUAB @BarrySleckman thanks for the invite to a wonderful cancer retreat… lots of promising young scientists setting the stage for major improvements in cancer care. #togoFASTgoALONEtogoFARgoTOGETHER #collaboration #cancerresearch
Devika Das, MD, MSHQS, FASCO retweeted
Dr. Rod Rocconi, Ergon Chair for Cancer Research and CCRI director, wears pink for Breast Cancer Awareness Month. This Boss’ Day, we’re grateful for his leadership and commitment to improving cancer outcomes across Mississippi.
Insurance coverage across state lines should not be a barrier for access to clinical trials ( neither should be the lack of insurance) 🥹 ‼️ #lcsm #bcsm #clinicaltrials @healthpolicycop @NCCN
Devika Das, MD, MSHQS, FASCO retweeted
Such a great story of perseverance and the power of positive attitude along with the power of excellent care. One patient at a time we’re creating #AHealthierMississippi #ONEmississippi #cancercareintheSIP #DeltaBlues
ICYMI: Mississippi blues legend Jesse Robinson isn’t letting cancer quiet his music. He shares how staying proactive and partnering with his UMMC care team keeps him doing what he loves. Watch his story: umc.edu/news/News_Articles/2…
Devika Das, MD, MSHQS, FASCO retweeted
A major investment in the future of cancer care in Mississippi: Regions Bank has committed $2.5M to the UMMC Cancer Center and Research Institute campaign, its largest charitable gift ever.
Read more: umc.edu/news/News_Articles/2…
Devika Das, MD, MSHQS, FASCO retweeted
The CCRI team and Breast Cancer Working Group is wearing pink for the beginning of Breast Cancer Awareness Month. The start of October is a reminder to learn your risks and talk with your doctor about screening. Early detection saves lives.
Devika Das, MD, MSHQS, FASCO retweeted
That ranking sounds a tad low!!! Grateful to work for an organization that is dedicated to the mission of caring for all Mississippians #AHealthierMississippi #ONEmississippi #healthcareintheSIP #AimingForNumberOne
UMMC is No. 2 on @Forbes' 2026 list of America's Best Employers for Healthcare Professionals.
The recognition reflects the people who make UMMC what it is and places Mississippi's academic medical center among the nation's top employers.
Read more at: umc.edu/news/News_Articles/2…
Devika Das, MD, MSHQS, FASCO retweeted
Daraxonrasib has been added to NCCN guidelines for KRASmt non-small cell lung cancer. Dose at 200 mg instead of 300 . Great speed, many patients that will benefit from this swift inclusion. @RevMedicines
Devika Das, MD, MSHQS, FASCO retweeted
OP Acknowledgment of Reviewers 2026.
Read the full article. bit.ly/4h7RfjX
Devika Das, MD, MSHQS, FASCO retweeted
🇺🇸 Where is the strongest oncology workforce capacity in the U.S.?
We developed an exploratory Oncology Workforce Capacity Index (OWCI) integrating Hem/Onc physician supply, fellowship training, demographic need, economic capacity, and labor environment.
The striking finding: oncology workforce capacity varies dramatically across states.
This isn’t a measure of cancer-care quality—it highlights how differently oncology resources and infrastructure are distributed across the country.
Could this help identify where future workforce investment is needed most? 🩸🎗️
#Hematology #Oncology #CancerCare #HealthcareWorkforce #HealthPolicy #MedEd #USMIRC
Devika Das, MD, MSHQS, FASCO retweeted
Beautiful work over many years by @DanaFarber team brought to fruition by Drs. Piccolo and Janne, a founder mutation from colonial USA leading to lung cancer risk - history and health collide! #lcsm
science.org/doi/10.1126/scie…
Great opportunity to be part of a mission driven team. Everyone here is passionate about building a high quality cancer program for Mississippians! Meet the team at #ASTRO26 👏👏👏
Many places. One team. One Mississippi home. Our UMMC #radonc team has come together from across the U.S. and around the world, bringing different experiences and perspectives to one shared mission: caring for Mississippi. Heading to #ASTRO26? Come meet us at Booth #1559 and learn more about opportunities to build your career, community, and future in Mississippi. Interested in connecting? Scan the QR code and let us know you’re coming.
Publication alert! 🚨 Grateful to be included in this SEER data base analysis.
🧐 Hypothesis generating observations which could use lead to further study and improvement projects.
📍I suspect a lot of heath and screening behaviors leading to seasonal cancer diagnosis are around health care access challenges including meeting deductibles etc and cancer awareness months and activities do help. Congratulations to the wonderful authors/ my colleagues 👏👏
@AYasinzaiMD @TGeorgeMD @JAMANetworkOpen
jamanetwork.com/journals/jam…
Rural academic thoracic oncology perspective as I am now parsing through the #WCLC26 data #lcsm
Great year and momentum for #SCLC
📍 Maverick data is phenomenal to spare patients PCI and cognitive decline but absolutely need access to high quality and timely MRI access ( cumulative brain Mets in the Non PCI cohort was higher)
📍 sequencing therapies and new targets specially with Anti B7-H3 ADC ( and others like SEZ) weaved in with Tarlatamab will likely change the landscape of treatment and survival. Inclusion of rural patients with ECOG 2 in the global trials for these/similar agents is key as our population can be often older, frailer and with more commodities. #TAISHAN-302 #ARTEMIS-008